FinnCap reiterated their corporate rating on shares of Avacta Group (LON:AVCT) in a report published on Wednesday morning, ThisIsMoney.Co.Uk reports.

LON:AVCT opened at GBX 150 ($1.85) on Wednesday. Avacta Group has a 1 year low of GBX 1.06 ($0.01) and a 1 year high of GBX 215.36 ($2.65). The stock has a fifty day moving average price of GBX 129.72 and a two-hundred day moving average price of GBX 77.63. The stock has a market capitalization of $373.73 million and a price-to-earnings ratio of -16.30.

Avacta Group Company Profile

Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. It operates through two segments, Life Sciences and Animal Health. The company's custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

Featured Article: Determine Your Level of Risk Tolerance

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with's FREE daily email newsletter.